Healthcare

According to a market report by Lucintel, the future of the immunofluorescence assay market looks promising with opportunities in the academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers. The global immunofluorescence assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of CAGR of 5.9% from 2023 to 2028. The major drivers for this market are increasing incidences of chronic diseases, growing government investments in healthcare, and rising R&D activities for technological advancements.  



In this market, indirect immunofluorescence and direct immunofluorescence are the major type segments. Lucintel forecasts that indirect immunofluorescence is expected to witness the highest growth over the forecast period as it ensures flexibility and better amplification of the signal. Also, it is more economical as compared to direct immunofluorescence.



Within this market, pharmaceutical & biotechnology companies are expected to witness the highest growth over the forecast period due to increasing use of these assays in the study of various diseases and drug discovery & development processes.



North America is expected to remain the largest region over the forecast period due to rising prevalence of chronic diseases, increasing spending in research and development activities, and favorable government funding opportunities in the region.

Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, PerkinElmer, Merck KGaA, Werfen Company, Cell Signaling Technology, MEDIPAN GmbH, Sino Biological, Danaher Corporation, Maravai LifeSciences, Enzo Biochem, Becton, Dickinson and Company, Olympus Corporation, and Nikon Corporation are the major suppliers in the global immunofluorescence assay market.  



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global immunofluorescence assay market by type, product, disease, end use, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Immunofluorescence Assay Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global immunofluorescence assay market by type, product, disease, end use, and region, as follows:

 

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the global immunofluorescence assay market by type (indirect immunofluorescence and direct Immunofluorescence), product (antibodies, reagents, kits, instruments, and consumables and accessories), disease (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, and other), end use (academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?